You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
戴維醫療(300314.SZ)擬參與設立象商基金 重點投資於先進製造等高新技術產業與戰略性新興產業領域
格隆匯 03-22 18:35

格隆匯 3 月 22日丨戴維醫療(300314.SZ)公佈,為進一步優化公司資產結構,增加投資收益,藉助資本市場實現持續發展,公司擬參與投資寧波燕創象商創業投資合夥企業(有限合夥)(“合夥企業”或“象商基金”)(暫定名,最終名稱以工商登記信息為準)。象商基金為有限合夥制,寧波燕園創業投資有限公司為普通合夥人,同時擔任執行事務合夥人。象商基金目標總認繳出資額為2.7億元,公司將作為有限合夥人擬使用自有資金投入人民幣1000萬元。

象商基金投資方向:重點投資於生物技術、醫藥與醫療器械、新材料、新能源、集成電路、新一代信息技術、先進製造等高新技術產業與戰略性新興產業領域。

公司此次利用自有資金參與設立象商基金,不會影響公司正常的生產經營活動,不會對公司現金流及經營業績產生重大不利影響,不存在損害上市公司及全體股東利益的情形。另外,此次對外投資是為了充分利用各方優勢資源,通過專業化投資管理團隊,積極尋找具有良好發展前景的項目,拓展投資渠道,進一步拓寬資金收益來源,服務於公司未來戰略佈局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account